Agilent Technologies Inc. (A) SureSelect Target Enrichment Now Available for Ion Proton Next-Generation Sequencing Systems  
10/22/2013 9:58:20 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today introduced a new SureSelect target enrichment solution that allows Ion Proton users to realize the full power of their next-generation sequencers with the industry’s leading human exome and custom DNA target enrichment solutions. SureSelect target enrichment is now available for all major sequencing platforms, enabling researchers to achieve the highest-performance target enrichment results with a variety of sequencers.

Help employers find you! Check out all the jobs and post your resume.